Janssen HLA - Search Results

1

A global scientific strategy to cure hepatitis B.

Revill PA, Chisari FV, Block JM, Dandri M, Gehring AJ, Guo H, Hu J, Kramvis A, Lampertico P, Janssen HLA, Levrero M, Li W, Liang TJ, Lim SG, Lu F, Penicaud MC, Tavis JE, Thimme R; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors; Zoulim F. Revill PA, et al. Among authors: janssen hla. Lancet Gastroenterol Hepatol. 2019 Jul;4(7):545-558. doi: 10.1016/S2468-1253(19)30119-0. Epub 2019 Apr 10. Lancet Gastroenterol Hepatol. 2019. PMID: 30981686 Free PMC article.

2

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

3

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression.

Janssen HL, Higuchi H, Abdulkarim A, Gores GJ. Janssen HL, et al. J Hepatol. 2003 Sep;39(3):414-20. doi: 10.1016/s0168-8278(03)00265-4. J Hepatol. 2003. PMID: 12927928

4

Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients.

van der Eijk AA, Niesters HG, Hansen BE, Pas SD, Richardus JH, Mostert M, Janssen HL, Schalm SW, de Man RA. van der Eijk AA, et al. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1173-9. doi: 10.1097/00042737-200511000-00004. Eur J Gastroenterol Hepatol. 2005. PMID: 16215428

5

The effect of pegylated interferon-alpha on the treatment of lamivudine resistant chronic HBeAg positive hepatitis B virus infection.

Leemans WF, Flink HJ, Janssen HL, Niesters HG, Schalm SW, de Man RA. Leemans WF, et al. J Hepatol. 2006 Mar;44(3):507-11. doi: 10.1016/j.jhep.2005.12.004. Epub 2006 Jan 19. J Hepatol. 2006. PMID: 16457904

6

Future prospectives for the management of chronic hepatitis B.

Leemans W, Janssen HL, de Man R. Leemans W, et al. World J Gastroenterol. 2007 May 14;13(18):2554-67. doi: 10.3748/wjg.v13.i18.2554. World J Gastroenterol. 2007. PMID: 17552002 Free PMC article. Review.

7

Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.

Leemans WF, Niesters HG, van der Eijk AA, Janssen HL, Schalm SW, de Man RA. Leemans WF, et al. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7. doi: 10.1097/MEG.0b013e3282f793d6. Eur J Gastroenterol Hepatol. 2008. PMID: 18617782

8

Experimental models for hepatitis C viral infection.

Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL. Boonstra A, et al. Hepatology. 2009 Nov;50(5):1646-55. doi: 10.1002/hep.23138. Hepatology. 2009. PMID: 19670425 Review.

9

Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.

Buster EH, Hansen BE, Lau GK, Piratvisuth T, Zeuzem S, Steyerberg EW, Janssen HL. Buster EH, et al. Gastroenterology. 2009 Dec;137(6):2002-9. doi: 10.1053/j.gastro.2009.08.061. Epub 2009 Sep 6. Gastroenterology. 2009. PMID: 19737568

10

Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.

Reijnders JG, Deterding K, Petersen J, Zoulim F, Santantonio T, Buti M, van Bömmel F, Hansen BE, Wedemeyer H, Janssen HL; VIRGIL Surveillance Study Group. Reijnders JG, et al. J Hepatol. 2010 Apr;52(4):493-500. doi: 10.1016/j.jhep.2010.01.012. Epub 2010 Feb 4. J Hepatol. 2010. PMID: 20185191 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

567 results

Search Page

Filters